Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Blood Sample Collection

Posted on By

Protocol for Venous Blood Collection in BA/BE Studies

Pugrpose

The purpgose of this Standard Operating Procedure (SOP) is to establish guidelines for the safe and standardized collection of venous blood samples from study participants in Bioavailability (BA) and Bioequivalence (BE) studies conducted in the pharmaceutical industry.

Scgogpe

This SOP applies to all personnel involved in the collection, handling, and processing of venous blood samples, including Clinical Reseagrch Associates (CRAs), Study Nurses, Phlebotomists, and Laboratory Personnel.

Regsponsibilities

  • The Study Coordinator is responsible for coordinating blood sample collection activities and ensuring adherence to the study protocol and regulatory requirements.
  • The Study Nurse, Phlebotomist, or designated personnel are responsible for performing venous blood collection procedures ggaccording to established protocols and safety guidelines.
  • The Laboratory Personnel are responsible for receiving, processing, and analyzing blood samples, ensuring proper handling and gdocumentation throughout the process.
See also  SOP for Handling Protocol Deviations

Procdure

  1. Review the study protocol and participant medical records to determine the timing, volume, and frequency of blood sample collection.
  2. Prepare the necessary equipment and supplies for blood collection, including venipuncture needles, collection tubes, and specimen labels.
  3. Obtain informed consent from study participants before initiating any blood collection procedures, ensuring that they understand the purpose and risks involved.
  4. Perform venous blood collection using aseptic techniques and standard venipuncture procedures, ensuring patient comfort and safety.
  5. Label
blood collection tubes accurately with participant identifiers, collection date and time, and any other required information.
  • Process blood samples promptly according to the study protocol, including centrifugation, aliquoting, and storage under appropriate conditions.
  • Transport processed samples to the laboratory for analysis, maintaining proper chain of custody and temperature control during transit.
  • Document all blood sample collection activities, including participant consent, collection details, and any adverse events or deviations encountered.
  • Abbreviations

    • SOP – Standard Operating Procedure
    • BA – Bioavailability
    • BE – Bioequivalence
    • CRA – Clinical Research Associate

    Documents

    • Blood Sample Collection Log
    • Participant Consent Forms
    • Specimen Labels
    • Sample Processing Records

    Reference

    International Conference on Harmonisation (ICH) E6 Good Clinical Practice guidelines and relevant regulatory requirements for blood sample collection and handling.

    SOP Version

    Version 1.0

    See also  SOP for Bioanalytical Method Validation
    Bioequivalence Bioavailability Study Tags:AUC (area under the curve), BE assessment, Bioavailability study, Bioequivalence study, clinical trials, Cmax (maximum concentration), Comparative pharmacokinetics, Drug absorption, Drug absorption rate, Drug bioanalysis, Drug development, Drug dissolution, Drug formulation, Drug metabolism, In vitro bioequivalence, In vivo bioavailability, Pharmacokinetic parameters, Pharmacokinetics, SOP for Bioavailability study, SOP for Bioequivalence study, Therapeutic equivalence, Tmax (time to maximum concentration)

    Post navigation

    Previous Post: SOP for Pharmacokinetic Sampling
    Next Post: SOP for Handling and Processing Plasma

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version